MIF and miotic rate: To date, the clinical application of circulating biomarkers of MIF has met several limitations, as most of the proposed biomarkers have not been shown to sufficiently reflect the structural, functional, or molecular alterations associated with MR in patients with HHD, or a lack of significant association has been found with histologically proven MIF [21].